Marius Pharmaceuticals, a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke University School of Medicine to explore the ...

Market Value: The global nanoscale chemicals market is expected to grow from USD 5 billion in 2022 to USD 11.84 billion by 2032. CAGR Growth: The market is projected to expand at a robust CAGR of 9% ...

Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...

Scheme not only benefits the domestic economy but also has positive ripple effects on the global stage, enhancing ...

More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or argenx SE is a better investment based on AAII's A+ Investor grades ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...

Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.

The policy environment for rare disease and orphan medicines is complex and encompasses regulation, reimbursement, and ...

Learn more about whether Exact Sciences Corporation or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Viatris reported mixed results for Q4 2024, missing revenue and EPS expectations, despite noteworthy debt reduction and portfolio adjustments.